Category Specific RSS

cannabis

Clinical trial reveals promising outcomes for children with paediatric autoimmune neuropsychiatric disorders

PANDAS and PANS are debilitating conditions characterised by distressing symptoms, ranging from rage to signs of obsessive compulsive disorder.

2 years ago

Bod Science’s Aqua Phase cannabis outperforms oil-based cannabis in absorption, concentration and onset speed

Traditional cannabis in the form of oil has had an absorption problem, making it less effective. But what if you…

2 years ago

Vitura declares dividend for the second time amid growing cannabis profits

Once again, medical cannabis producer Vitura Health (ASX: VIT) has become the only ASX-listed company operating in the medicinal cannabis…

2 years ago

Melodiol divests Sierra Sage Herbs and Halucenex for $8 million after acquiring them for over $20 million

After changing its name and identity, cannabis and psychedelics provider Melodiol (ASX: ME1) has decided to sell off two of…

2 years ago

Living Cell Technologies latest project targets dementia with cannabinoid-based drug

As of 2022, Australia is witnessing nearly 400,000 individuals grappling with dementia. Dementia is the second leading cause of death…

2 years ago

Cannabis lemonade and iced teas: Althea’s Peak teams up with Tweed to bring cannabis-infused products to Canada

Cannabis is the most widely-used illicit drug worldwide; about 2.5% of the world, i.e. approximately 150 million people, consume cannabis,…

2 years ago